Cerbios-Pharma SA

Via Figino 6
6917 Barbengo – Lugano
Switzerland

Contact WebSite

With over 40 years in the pharmaceutical industry, Cerbios is a privately held company with headquarter in Barbengo-Lugano, Switzerland, specialising in the development and manufacture of both chemical and biological APIs for its partners worldwide. Beyond the development of its own product pipeline, Cerbios offers exclusive third-party CDMO services for High Potency Active Pharmaceutical Ingredients (HPAPIs), recombinant proteins and Antibody Drug Conjugates (ADCs) from preclinical through clinical to commercial supply.

Article

Experts Statements: Gabriel Haering, Cerbios Pharma
05.09.2019 • Topics • Strategy

Experts Statements: Gabriel Haering, Cerbios Pharma

The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021.

Francesca Scarpitta Joins Cerbios as Director of HPAI Manufacturing Units
24.01.2019 • News

Francesca Scarpitta Joins Cerbios as Director of HPAI Manufacturing Units

Cerbios has appointed Francesca Scarpitta as director of the company’s high potency active ingredients (HPAIs) production units.

Cerbios Expands HPAI Manufacturing Capacity
24.01.2019 • News

Cerbios Expands HPAI Manufacturing Capacity

Lugano, Switzerland-based chemical and biological API manufacturer Cerbios announced that its board of directors has approved the installation of a new production line in its building dedicated for high potency active ingredients (HPAIs).

Cerbios' new State-of the-art R&D Centre for HPAI and mAb Development
21.09.2016 • Topics • Strategy

Cerbios' new State-of the-art R&D Centre for HPAI and mAb Development

Value Over Price
11.09.2013 • Topics • Technology

Value Over Price